Skip to main content

The Role of Azilsartan in Achieving The New Blood Pressure Targets in Hypertension

Enroll in CV005

Offered by cv-live



  • Price:


  • Language:


  • Commitment:

Share your Case Studies

Come join our "Learn as you Teach" initiative to democratise healthcare learning by submitting your unique & interesting Case-Studies which will be reviewed by our global medical fraternity as well as an opportunity to be published in leading research journals.

Flow of the CME Lecture:

15 mins : Presentation by Dr. Michael Weber

- Background to Hypertension 'HTN', its epidemiology,
- Why we treat HTN?
- What our treatment targets are?
- How an innovative drug like azilsartan is important in HTN treatment?
- Azilsartan's formulation and how it differs from other ARBs and it workings

15 mins : Presentation by Dr.Brian Pinto

Clinical data on the drug
Case-Study Approach

30 mins : Discussion and Q & A

Meet the Instructors

Course Staff Image #1

Dr.Michael Weber

Professor of Medicine,
Department of Medicine (Cardiology),
State University of New York Downstate College of Medicine,
Brooklyn, USA.

Dr. Brian Pinto

DM Cardiology,
Chief Cardiologist at Holy Family Hospital,